BamSEC and AlphaSense Join Forces
Learn More

Ligand Pharmaceuticals Incorporated

NASDAQ: LGND    
Share price (12/20/24): $114.64    
Market cap (12/20/24): $2.166 billion
Search in Documents
Key Exhibits
External Links

Credit Agreements Filter

EX-10.1
from 10-Q 12 pages First Amendment to Credit Agreement
12/34/56
EX-10.1
from 8-K 150 pages Credit Agreement Dated as of October 12, 2023 Among Ligand Pharmaceuticals Incorporated, as the Borrower, the Subsidiaries of the Borrower Party Hereto, as the Guarantors, Citibank, N.A., as Administrative Agent, Swingline Lender and L/C Issuer, and the Lenders Party Hereto ************************************************ Citibank, N.A., as Sole Lead Arranger and Sole Bookrunner
12/34/56
EX-10.1
from 10-Q 2 pages Third Amendment to Loan and Security Agreement
12/34/56
EX-10.1
from 10-Q/A 4 pages Second Amendment to Loan and Security Agreement
12/34/56
EX-10.1
from 10-Q 4 pages Second Amendment to Loan and Security Agreement
12/34/56
EX-10.2
from 10-Q ~5 pages First Amendment to Loan and Security Agreement
12/34/56
EX-10.1
from 10-Q 29 pages Loan and Security Agreement
12/34/56
EX-10.01
from 8-K 13 pages Sixth Amendment to Loan and Security Agreement
12/34/56
EX-10.1
from 8-K 3 pages Second Amendment to Loan and Security Agreement
12/34/56
EX-10.134
from 10-K 21 pages Fourth Amendment to Loan and Security Agreement
12/34/56
EX-10.130
from 10-K 9 pages Joinder and Second Amendment to Loan and Security Agreement
12/34/56
EX-10.1
from 8-K 20 pages Fourth Amendment to Loan and Security Agreement
12/34/56
EX-10.2
from 8-K 5 pages First Amendment to Loan and Security Agreement
12/34/56
EX-10.1
from 8-K 3 pages First Amendment to Loan and Security Agreement
12/34/56
EX-10.1
from 8-K 22 pages Ligand Pharmaceuticals, Incorporated Loan and Security Agreement
12/34/56
EX-10.3
from 8-K 46 pages Loan and Security Agreement
12/34/56
EX-10.303
from 10-K 17 pages Loan Agreement
12/34/56